3/28
04:19 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
High
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
3/28
04:10 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
High
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
3/11
08:17 pm
antx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
3/9
12:00 pm
antx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
3/7
05:05 pm
antx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
3/5
04:45 pm
antx
Levi & Korsinsky, LLP Investigates Possible Securities Fraud Violations by AN2 Therapeutics, Inc. (ANTX)
Low
Report
Levi & Korsinsky, LLP Investigates Possible Securities Fraud Violations by AN2 Therapeutics, Inc. (ANTX)
3/5
12:15 pm
antx
ANTX ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AN2 Therapeutics, Inc.
Low
Report
ANTX ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AN2 Therapeutics, Inc.
3/3
10:30 am
antx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
11/9/2023
04:05 pm
antx
an2 therapeutics, inc.
MISS
Report
-7.1%
an2 therapeutics, inc.
8/10/2023
04:10 pm
antx
an2 therapeutics, inc.
BEAT
Report
0.4%
an2 therapeutics, inc.
5/11/2023
04:10 pm
antx
an2 therapeutics, inc.
MISS
Report
0.6%
an2 therapeutics, inc.
4/10
04:45 pm
antx
Form SC 13G AN2 Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Low
Report
Form SC 13G AN2 Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
4/5
04:14 pm
antx
Form PRE 14A AN2 Therapeutics, Inc. For: Jun 19
Low
Report
Form PRE 14A AN2 Therapeutics, Inc. For: Jun 19
3/29
05:11 pm
antx
Form S-8 AN2 Therapeutics, Inc.
High
Report
Form S-8 AN2 Therapeutics, Inc.
3/29
04:25 pm
antx
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
High
Report
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
3/29
04:19 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
3/29
04:19 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
3/29
04:18 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
3/29
04:17 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register